Royal Park Health and Rehab: Repeat Medication Delays - WA
The most recent inspection, completed January 17, 2025, found that Royal Park Health and Rehabilitation left at least two residents without their prescribed drugs, including one awaiting an expensive injectable medication that no staff member had formally authorized until the day inspectors arrived.
The first resident was waiting on amitriptyline, a medication used to treat depression, nerve pain, and other conditions. Staff Z, interviewed by inspectors that afternoon, said it had been passed along in a shift report that the drug had been ordered from the pharmacy. Getting it, Staff Z acknowledged, had been a problem. There may have been an insurance issue, they said. But they had not entered the wrong code. They had not given the medication. It simply had not come from the pharmacy yet.
How long the resident had gone without the medication is not stated in the inspection report.
The second resident, identified as Resident 156, was waiting on Enbrel, a high-cost injectable drug used to treat autoimmune conditions including rheumatoid arthritis. The Director of Nursing, Staff B, told inspectors that afternoon that she had signed the authorization for Resident 156's Enbrel that same day, January 17, the day of the inspection. Authorization was required, she explained, for any medication above a certain cost threshold.
Staff B said she expected to receive an email when an authorization was needed. She did not remember getting one for the Enbrel.
Nobody had.
The authorization sat unsigned while the resident's doses went unmissed only in the sense that no one had tracked what was being missed. Staff B told inspectors her expectation was that staff would call the pharmacy and notify the provider so medication doses were not skipped. Whether that happened, and when, the report does not say.
What the report does say is that this is the third time inspectors have cited Royal Park for this same category of failure. The first citation came during a recertification survey on October 4, 2023. The second came on March 7, 2024. The January 2025 inspection marks the third.
The same problem, the same facility, across three separate surveys spanning 15 months.
The level of harm documented in this inspection was classified as minimal harm or potential for actual harm, and the number of residents affected was listed as few. Those are the two lowest tiers in the federal harm scale. They do not mean nothing happened. They mean inspectors could not document that serious injury had yet occurred.
For a resident with an autoimmune condition waiting on Enbrel, or a resident waiting on amitriptyline for nerve pain or depression, the clinical consequences of missed doses depend on factors the inspection report does not detail. What the report does detail is a system that failed in the same way, at the same facility, across three different inspection cycles, and was still failing on the day inspectors walked in.
Staff B signed the Enbrel authorization that afternoon. Whether Resident 156 received their next dose on schedule, the record does not say.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Royal Park Health and Rehabilitation from 2025-01-17 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: November 22, 2026 · Our methodology
Royal Park Health and Rehabilitation in SPOKANE, WA was cited for violations during a health inspection on January 17, 2025.
The first resident was waiting on amitriptyline, a medication used to treat depression, nerve pain, and other conditions.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.
